Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

NCT00136760 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia and Disorders With Psychotic Features
Tobacco Use Disorder

Interventions

DRUG: Bupropion
DRUG: Contingent reinforcement plus placebo
DRUG: non-contingent reinforcement plus bupropion
DRUG: Non-contingent reinforcement plus placebo

Sponsor

Brown University

Collaborators

[object Object]